IPSC

1.16511.74%
MP

Martin Patrick Murphy

Independent Director

Dr. Martin Patrick Murphy was Independent Non-Executive Director of Synairgen plc from January 16, 2025 to March 31, 2026 and also served as it's Chair. Dr. Murphy is Non Executive Director of Pulmagen Therapeutics (Synergy) Limited. Dr. Murphy is Chief Executive of Project Sigma of Wellcome Trust, Investment Division. Dr. Murphy is Director of Century Therapeutics, Inc. from December 9, 2025. Dr. Murphy is Director of Clade Therapeutics, Inc. Dr. Murphy was Executive Officer of McKinsey & Company, Inc. Dr. Murphy was Investment Professional of 3i Group plc. Dr. Murphy focused on Healthcare. Dr. Murphy was Director of Horizon Discovery Group Limited. Dr. Murphy was Chairman of Serentis Limited. Dr. Murphy was Director of PregLem SA. Dr. Murphy was Director of Vantia Ltd. Dr. Murphy was Director of Blue Earth Diagnostics Limited. Dr. Murphy was Chairman of Biomodal Limited. Dr. Murphy was employed at Biomodal Limited. until March 17, 2016. Dr. Murphy was Director of 14M Genomics Ltd. Dr. Murphy was Non-Executive Director of Autolus Limited until June 22, 2018. Dr. Murphy was employed at Autolus Limited until June 22, 2018. Dr. Murphy was Independent Non-Executive Director of Achilles Therapeutics plc. Dr. Murphy was Chairman of Achilles Therapeutics plc. Dr. Murphy was Investment Manager and Partner of MVM Partners LLP. Dr. Murphy was CEO, Member of Board of Directors & Member of Advisory Board of Syncona Partners LLP until 2023. Dr. Murphy was employed at Syncona Partners LLP until 2023. Dr. Murphy was Co-Founder & Chairman of Syncona Investment Management Limited. Dr. Murphy was Co-Founder, CEO & Chairman of Syncona Investment Management Limited. Dr. Murphy joined the Syncona Investment Management Limited in 2012. Dr. Murphy was Independent Non-Executive Director of Autolus Therapeutics plc until July 2025. Dr. Murphy was Non-Executive Director of Autolus Therapeutics plc from September 15, 2021. Dr. Murphy was Non-Executive Chairman of Autolus Therapeutics plc from April 15, 2021 to September 15, 2021. Dr. Murphy was Independent Non-Executive Director of Autolus Therapeutics plc from September 2014 to April 15, 2021. Dr. Murphy was employed at Autolus Therapeutics plc until July 2025. Dr. Murphy was Chairman of Anaveon AG until July 2024. Dr. Murphy was employed at Anaveon AG until July 2024. Dr. Murphy was Chairman of Quell Therapeutics Ltd until July 2024. Dr. Murphy was employed at Quell Therapeutics Ltd until July 2024. Dr. Murphy was Director of Resolution Therapeutics Limited from December 02, 2020. Dr. Murphy has Ph.D. in Biochemistry & Molecular Biology from University of Cambridge in 1994, M.A. in Biochemistry from University of Oxford.

Positions